Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cardio Catch-Up: Trial Of Abbott’s Volt PFA Begins; IDE Study To Start This Year

Jan 24 2024

• By Reed Miller

Abbott Volt PFA — Abbott Volt PFA • Source: Abbott

Related Content

Cardio Catch-Up: Trial Of Biosense Webster’s Dual-Energy Ablation System Finishes Enrollment

Jul 21 2023

Cardio Conversations: Abbott's Electrophysiology CMO Christopher Piorkowski On Cardiac Mapping, PFA, VT And More

Mar 02 2023

News We’re Watching: Philips And Walgreens Settlements, ReCor Readies For Takeoff, Farapulse Trial Results

Sep 08 2023

Cardio Conversations: Steven Mickelsen Discusses PFA, Electrophysiology And What It Takes To Be A Physician Inventor

Jan 21 2023

First PFA In The US: FDA Approves Medtronic’s PulseSelect For AF Ablation

Dec 14 2023

News We’re Watching: Boston Scientific Updates PFA Progress, Novel Vibrating Pill For Obesity, And More

Jan 02 2024

Related Companies

Biosense Webster Inc

Medtronic plc

Boston Scientific Corporation

Additional Topics

Commercial Approvals Clinical Trials Research & Development Cardiology Medical Device

More from Business

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window